These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 6468835)

  • 21. Carcinogenicity of butylated hydroxyanisole in F344 rats.
    Ito N; Fukushima S; Hagiwara A; Shibata M; Ogiso T
    J Natl Cancer Inst; 1983 Feb; 70(2):343-52. PubMed ID: 6571941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Butylated hydroxyanisole and lung tumor development in A/J mice.
    Witschi HR; Doherty DG
    Fundam Appl Toxicol; 1984 Oct; 4(5):795-801. PubMed ID: 6510611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The carcinogenic effect of butylated hydroxyanisole on the stratified epithelium of the stomach in rat versus pig.
    Olsen P
    Cancer Lett; 1983 Nov; 21(1):115-6. PubMed ID: 6640510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of oxidative DNA damage and early lesions in rat gastro-intestinal epithelium in relation to prostaglandin H synthase-mediated metabolism of butylated hydroxyanisole.
    Schilderman PA; ten Vaarwerk FJ; Lutgerink JT; Van der Wurff A; ten Hoor F; Kleinjans JC
    Food Chem Toxicol; 1995 Feb; 33(2):99-109. PubMed ID: 7868004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Butylated hydroxyanisole (BHA) does not cause forestomach hyperplasia by inhibiting the release of gastric mucus.
    Lauriault V; Grasso P; Powell CJ
    Toxicology; 1990 Dec; 64(3):281-90. PubMed ID: 2125152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term pathological and proliferative effects of butylated hydroxyanisole and other phenolic antioxidants in the forestomach of Fischer 344 rats.
    Nera EA; Lok E; Iverson F; Ormsby E; Karpinski KF; Clayson DB
    Toxicology; 1984 Sep; 32(3):197-213. PubMed ID: 6474484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition by dehydroepiandrosterone of butylated hydroxyanisole (BHA) promotion of rat-bladder carcinogenesis and enhancement of BHA-induced forestomach hyperplasia.
    Shibata MA; Shirai T; Asakawa E; Hirose M; Fukushima S
    Int J Cancer; 1993 Mar; 53(5):819-23. PubMed ID: 8449607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid regression of squamous cell hyperplasia and slow regression of basal cell hyperplasia in the forestomach of F344 rats treated with N-methyl-N'-nitro-N-nitrosoguanidine and/or butylated hydroxyanisole.
    Tatematsu M; Ogawa K; Mutai M; Aoki T; Hoshiya T; Ito N
    Cancer Res; 1991 Jan; 51(1):318-23. PubMed ID: 1703036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of cell proliferation in the forestomach of F344 rats following subchronic administration of styrene 7,8-oxide and butylated hydroxyanisole.
    Cantoreggi S; Dietrich DR; Lutz WK
    Cancer Res; 1993 Aug; 53(15):3505-8. PubMed ID: 8339254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-response study on covalent binding to forestomach protein from male F344 rats following oral administration of [14C]3-BHA.
    Morimoto K; Takahashi T; Okudaira K; Iio T; Saito Y; Takahashi A
    Carcinogenesis; 1992 Sep; 13(9):1663-6. PubMed ID: 1394853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of lesions induced in the Syrian golden hamster by diethylnitrosamine, dimethylhydrazine, and dibutylnitrosamine: influence of subsequent butylated hydroxyanisole treatment.
    Moore MA; Thamavit W; Ito N
    J Natl Cancer Inst; 1987 Feb; 78(2):295-301. PubMed ID: 3468293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of BHA and related phenols on the forestomach of rats.
    Altmann HJ; Grunow W; Mohr U; Richter-Reichhelm HB; Wester PW
    Food Chem Toxicol; 1986; 24(10-11):1183-8. PubMed ID: 3804120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential modification of development of preneoplastic lesions in the Syrian golden hamster initiated with a single dose of 2,2'-dioxo-N-nitrosodipropylamine: influence of subsequent butylated hydroxyanisole, alpha-tocopherol, or carbazole.
    Moore MA; Tsuda H; Thamavit W; Masui T; Ito N
    J Natl Cancer Inst; 1987 Feb; 78(2):289-93. PubMed ID: 3468292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variation in susceptibility to the induction of forestomach tumours by butylated hydroxyanisole among rats of different strains.
    Tamano S; Hirose M; Tanaka H; Hagiwara A; Shirai T
    Food Chem Toxicol; 1998 Apr; 36(4):299-304. PubMed ID: 9651046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Butylated hydroxyanisole isomers induce distinct adipogenesis in 3T3-L1 cells.
    Sun Z; Yang X; Liu QS; Li C; Zhou Q; Fiedler H; Liao C; Zhang J; Jiang G
    J Hazard Mater; 2019 Nov; 379():120794. PubMed ID: 31238218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of BHA-induced proliferative rat forestomach lesion development by simultaneous treatment with other antioxidants.
    Hirose M; Masuda A; Tsuda H; Uwagawa S; Ito N
    Carcinogenesis; 1987 Nov; 8(11):1731-5. PubMed ID: 3664967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolism of 2- and 3-tert-butyl-4-hydroxyanisole (2- and 3-BHA) in the rat. (II): Metabolism in forestomach and covalent binding to tissue macromolecules.
    Hirose M; Asamoto M; Hagiwara A; Ito N; Kaneko H; Saito K; Takamatsu Y; Yoshitake A; Miyamoto J
    Toxicology; 1987 Jul; 45(1):13-24. PubMed ID: 3603573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disappearance of upward proliferation and persistence of downward basal cell proliferation in rat forestomach papillomas induced by butylated hydroxyanisole.
    Masui T; Asamoto M; Hirose M; Fukushima S; Ito N
    Jpn J Cancer Res; 1986 Sep; 77(9):854-7. PubMed ID: 3095280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the effects of 13 phenolic compounds in induction of proliferative lesions of the forestomach and increase in the labelling indices of the glandular stomach and urinary bladder epithelium of Syrian golden hamsters.
    Hirose M; Inoue T; Asamoto M; Tagawa Y; Ito N
    Carcinogenesis; 1986 Aug; 7(8):1285-9. PubMed ID: 3731382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition by 2(3)-tert-butyl-4-hydroxyanisole and other antioxidants of epidermal ornithine decarboxylase activity induced by 12-O-tetradecanoylphorbol-13-acetate.
    Kozumbo WJ; Seed JL; Kensler TW
    Cancer Res; 1983 Jun; 43(6):2555-9. PubMed ID: 6850576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.